Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Metronidazole
- Therapeutic area
- Anti-infectives
- Drug class
- Nitroimidazole anti-infectives
- ATC
- A02BD
- Strength
- 200 mg/5 mL
- Dosage form
- Suspension
- Pack
- 60 ml
- Registration no.
- 038617
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-10-07 02:55
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 57.48 to 60.32 (+4.9%) between 4 Sep 2025 and 28 Sep 2026 · 2 official price records · pack 60 ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Granid 200 mg/5 mL, 60 ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/granid-200-mg-5-ml-038617-60-ml-glitz-pharma/ (accessed 7 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 60.32 | 2026-09-28 | 2026-09-29 | DRAP PharmaPrice Index (refreshed from snapshot #91) | Current |
| PKR 57.48 | 2025-09-04 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 038617Price and registration data on this page were observed on 29 September 2026. Records change over time, so please cite the observation date alongside the access date.
